Home Search

lung cancer - search results

If you're not happy with the results, please do another search
Lung Cancer

Novel Therapeutic Target Could Lead to Lung Cancer Treatments

A mouse study by researchers at the Australian National University (ANU) and the Peter MacCallum Cancer Centre have discovered that a protein called Menin contributes to abnormal deactivation of specific genes in cancer cells.
Lung cancer, composite image

Lung Cancer Surgery Quality, Outcomes Vary Widely Across the U.S.

Research published today in JAMA Surgery from the Washington University School of Medicine has found that the quality of lung cancer surgery in the United States varies widely with patients whose surgery failed to meet established guidelines experiencing significantly worse outcomes.
Artificial DNA and Intelligence

Researchers Develop AI Tool Predicting Lung Cancer Risk

Boston scientists create “Sibyl”—an artificial intelligence tool able to accurately predict the risk of lung cancer in smokers and non-smokers.
Big genomic data visualization

Comprehensive Genomic Profiling in Lung Cancer

In this Inside Precision Medicine Webinar, our distinguished guest, Dr. Sandip Patel from UCSD, discussed the importance of comprehensive genomic profiling in lung cancer and other solid tumors to direct optimal standard of care for cancer patients. Dr. Robin Thomas presented data from a study evaluating the AVENIO Tumor Tissue Comprehensive Genomic Profiling Kit.
Lung cancer, conceptual image

Combining Bacteria and Targeted Therapy Promising in Lung Cancer Model

A combination of bacterial therapy with other treatment modalities may improve cancer treatment efficacy without additional toxicity, according to a report from Columbia Engineering researchers. They have developed a new approach for preclinical evaluation of bacterial therapies in lung cancer models.
X-ray style image of the top part of a woman's body showing the lungs highlighted and four red lung cancer tumors of different sizes

FDA Approves Cancer-Targeting Imaging Agent for Lung Cancer

The FDA approved the imaging agent Cytalux (pafolacianine) for use in lung cancer cases to help surgeons find and remove previously unidentified tumors.
Lung cancer, computer artwork.

Research Supports Power of Screening for Increasing Survival in Lung Cancer

Using low-dose CT to screen for lung cancer can dramatically improve survival for individuals diagnosed with early-stage cancer during the process, show results presented at the annual meeting of the Radiological Society of North America.
Lung cancer, computer artwork.

New Therapeutic Target for Lung Cancer Found

A new study in mice by Northwestern Medicine researchers demonstrates and describes a new gene that is responsible for activating an aggressive subtype of small-cell lung cancer. Findings that may lead to improved approaches and treatments.

Increased Lung Cancer Tumor Burden Linked to Circadian Rhythm Disruption

Scripps researchers observed mice that were exposed to the irregular, shifting light patterns had an increased tumor burden of 68% and found the culprit to be the heat shock factor 1 (HSF1) family of proteins, not previously associated with circadian disruption.

Amgen KRAS Inhibitor Shows Benefits in Lung Cancer Phase III  

Lung cancer patients with a KRAS G12C mutation showed benefits from Amgen’s KRAS inhibitor Lumakras compared with docetaxel.

Trending

Inside Precision Medicine